UA95601C2 - Метансульфонат этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1метил-1н- бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты и фармацевтическая композиция, которая его содержит - Google Patents
Метансульфонат этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1метил-1н- бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты и фармацевтическая композиция, которая его содержитInfo
- Publication number
- UA95601C2 UA95601C2 UAA200708221A UAA200708221A UA95601C2 UA 95601 C2 UA95601 C2 UA 95601C2 UA A200708221 A UAA200708221 A UA A200708221A UA A200708221 A UAA200708221 A UA A200708221A UA 95601 C2 UA95601 C2 UA 95601C2
- Authority
- UA
- Ukraine
- Prior art keywords
- methyl
- hexyloxycarbonylamino
- phenylamino
- imino
- pyridin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
В заявке описана новая, предназначенная для перорального применения лекарственная форма для действующего вещества, которым является этиловый эфир 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1-метил-1H-бензимидазол-5-карбонил) пиридин-2-иламино]пропионовой кислоты и его фармакологически приемлемые соли.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10209985A DE10209985A1 (de) | 2002-03-07 | 2002-03-07 | Oral zu applizierende Darreichungsform für 3-[(2-{[4-(Hexyloxycarbonylaminoimino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propinsäure-ethylester und dessen Salze |
Publications (1)
Publication Number | Publication Date |
---|---|
UA95601C2 true UA95601C2 (ru) | 2011-08-25 |
Family
ID=27771070
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200708221A UA95601C2 (ru) | 2002-03-07 | 2003-03-03 | Метансульфонат этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1метил-1н- бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты и фармацевтическая композиция, которая его содержит |
UA20041008096A UA81760C2 (ru) | 2002-03-07 | 2003-03-03 | Фармацевтическая композиция для перорального применения этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил) фениламино]метил}-1-метил-1н-бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты и способ ее получения |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA20041008096A UA81760C2 (ru) | 2002-03-07 | 2003-03-03 | Фармацевтическая композиция для перорального применения этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил) фениламино]метил}-1-метил-1н-бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты и способ ее получения |
Country Status (4)
Country | Link |
---|---|
CN (1) | CN101632668A (ru) |
DE (1) | DE10209985A1 (ru) |
UA (2) | UA95601C2 (ru) |
UY (1) | UY27694A1 (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6215239B2 (ja) | 2012-02-21 | 2017-10-18 | ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ | ダビガトランエテキシラートの経口医薬組成物 |
CN102793699B (zh) * | 2012-08-06 | 2014-06-04 | 严轶东 | 一种含有达比加群酯的药用组合物 |
CN104414995A (zh) * | 2013-09-04 | 2015-03-18 | 天津汉瑞药业有限公司 | 甲磺酸达比加群酯的药用组合物 |
CN104825422B (zh) * | 2014-09-29 | 2017-12-12 | 普济生物科技(台州)有限公司 | 含达比加群酯甲磺酸盐的药物组合物及其制备方法 |
CN105640909B (zh) * | 2014-11-14 | 2019-09-20 | 正大天晴药业集团股份有限公司 | 一种含有达比加群酯的药用组合物 |
US10449195B2 (en) | 2016-03-29 | 2019-10-22 | Shenzhen Pharmacin Co., Ltd. | Pharmaceutical formulation of palbociclib and a preparation method thereof |
CN114306245A (zh) | 2020-09-29 | 2022-04-12 | 深圳市药欣生物科技有限公司 | 无定形固体分散体的药物组合物及其制备方法 |
-
2002
- 2002-03-07 DE DE10209985A patent/DE10209985A1/de not_active Withdrawn
-
2003
- 2003-03-03 UA UAA200708221A patent/UA95601C2/ru unknown
- 2003-03-03 UA UA20041008096A patent/UA81760C2/ru unknown
- 2003-03-03 CN CN200910149806A patent/CN101632668A/zh active Pending
- 2003-03-06 UY UY27694A patent/UY27694A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN101632668A (zh) | 2010-01-27 |
DE10209985A1 (de) | 2003-09-25 |
UY27694A1 (es) | 2003-10-31 |
UA81760C2 (ru) | 2008-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY143734A (en) | Administration form for the oral application of 3-[(2-<[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl>-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof | |
MY145696A (en) | 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-menthyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethylester-methanesulfonate and its use as a medicament | |
ES2307041T3 (es) | Tableta que contiene ester etilico del acido 3-((2-((4-(hexiloxicarbonilamino-imino-metil)-fenilamino)-metil)-1-metil-1h-bencimidazol-5-carbonil)-piridin-2-il-amino)-propionico o sus sales. | |
UA84266C2 (ru) | Дозированная врачебная форма в виде таблетки или гранулы для перорального введения, которая содержит ингибитор pde 4 и поливинилпиролидон, способы ее получения и применения | |
MX2007015480A (es) | Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada. | |
TW200624126A (en) | New modified release tablet formulations for proton pump inhibitors | |
NO20023313L (no) | Nye substituerte benzimidazol doseringsformer og fremgangsmåte for anvendelse av samme | |
IL166489A (en) | Oral dosage form in single-dose administration containing at least two layers for the administration and use of flipridone | |
IL164699A (en) | Derivatives of diketohydrazine compounds and pharmaceutical compositions and medicaments containing the compounds as the active ingredient | |
WO2001022791A8 (en) | Controlled release compositions comprising nimesulide | |
NO20060445L (no) | Fast farmasoytisk preparat omfattende amisulprid | |
TW200640455A (en) | Oral dosage form comprising 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione | |
TW200633694A (en) | Composition and method for treating asthma | |
MXPA05009976A (es) | Metodo para incrementar la biodisponibilidad oral del 2-metilpropantioato de s-[2-([[1- 2-etilbutil) ciclohexil] carbonil] amino) fenilo]. | |
AU2003208761A1 (en) | A method for releasing nanosized particles of an active substance from a diffusion-controlled pharmaceutical composition for oral use | |
UA95601C2 (ru) | Метансульфонат этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1метил-1н- бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты и фармацевтическая композиция, которая его содержит | |
ZA200506992B (en) | Fibrate tablet and method for the production thereof | |
WO2006094640A3 (en) | Roflumilast and integrin inhibitor combination and method of treatment | |
AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
WO2003086319A3 (en) | Pharmaceutical compositions containing an hiv integrase inhibitor and a nonionic surfactant | |
TW201129557A (en) | Pharmaceutical composition for oral administration | |
WO2005115092A3 (en) | Micronized oral pharmaceutical composition | |
MY137801A (en) | Tablet for oral administration comprising 2-[(4-methoxy-3-methyl)-2-pyridinyl]methylsulfinyl-5-(1h-pyrrol-1-yl)-1h-benzimidazole | |
FR2878443B1 (fr) | Composition pharmaceutique, destinee a l'administration par voie orale de principe(s) actif(s) fortement gastro-labile(s et sa preparation |